Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Cardiff Oncology Inc’s stock clocked out at $4.23, down -7.24% from its previous closing price of $4.56. In other words, the price has decreased by -$7.24 from its previous closing price. On the day, 1.07 million shares were traded.
Ratios:
To gain a deeper understanding of CRDF’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.74 and its Current Ratio is at 4.74. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.Robert W. Baird initiated its Outperform rating on December 08, 2021, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Levine James E. bought 2,752 shares for $5.42 per share. The transaction valued at 14,905 led to the insider holds 65,316 shares of the business.
Levine James E. bought 2,400 shares of CRDF for $12,000 on Dec 18 ’24. The Chief Financial Officer now owns 67,716 shares after completing the transaction at $5.00 per share. On Dec 16 ’24, another insider, Levine James E., who serves as the Chief Financial Officer of the company, bought 2,564 shares for $3.83 each. As a result, the insider paid 9,820 and bolstered with 62,564 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 407.78 while its Price-to-Book (P/B) ratio in mrq is 4.17.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 3.68%, while the 200-Day Moving Average is calculated to be 39.71%.
Shares Statistics:
A total of 66.52M shares are outstanding, with a floating share count of 59.77M. Insiders hold about 10.15% of the company’s shares, while institutions hold 34.49% stake in the company.
